Melanoma cancer

Lung cancer Breast cancer Melanoma Colorectal cancer Hematologic malignancies (i.e., leukemia)... 

Melanoma renal cell cancer Melanoma renal cell cancer Head and neck, lung, and breast cancer Hepatitis C... 

Humanized and chimerized MAbs have been developed for the treatment of non-Hodgkin lymphoma, renal cell carcinoma, ovarian carcinoma, breast cancer, melanoma, and neuroblastoma [117,119,120,123,124]. Patients with relapsed or refractory myeloid leukaemias that have been treated with HuM95, did not develop significant HAMA responses [59]. 

Temozolomide Methylates DNA and inhibits DNA synthesis and function Brain cancer, melanoma Nausea and vomiting, headache and fatigue Myelosuppression, mild elevation in liver function tests, photosensitivity... 

In one report, the optical gradient field (/l = 808 nm) was used to interact with cells and beads and to measure the resultant time-of-flight. This method (known as optophoresis) has successfully differentiated between cancerous versus non-cancerous cells (breast cancerous melanoma) [867]. 

DAC (decitabine) I Advanced solid tumors, bladder cancer, breast cancer, male breast cancer, melanoma NCI/USC... 

The ozone layer around the Earth has provided us all a natural ring of protection from harmful UV radiation. However, multiple anthropogenic activities have acted as barriers and often caused damage to this shield. Less protection from UV light will, over time, lead to increased health problems and crop damage. Major health problems linked to overexposure to UV radiation by the depletion of ozone include skin cancer (melanoma and nonmelanoma), premature aging of the skin and other skin problems, cataracts and other eye damage, and suppression of normal immune system function.29... 

High risk of EBV related B cell neoplasms, skin cancer, melanoma, leukemia, breast cancer, adenocarcinoma... 

Vinblastine is used in combination with other cytotoxic agents for the treatment of disseminated Hodgkin s disease stages III and IV, non-Hodgkin s lymphoma, histiocytic lymphoma, and advanced carcinoma of the testis. It has also been used for the treatment of bladder cancer, melanoma, and renal cell cancer. The usual adult dosage is 3-6 mg/m intravenously for the treatment of testicular germ cell tumors and Hodgkin s disease (1,2). 

Human Cervical Carcinoma Human Non Small Cell Lung Cancer Melanoma... 

Paclitaxel (Taxol ) and its semisynthetic analogue docetaxel (see Figure 5.1) are two of the most important chemotherapeutic drugs, currently used for the treatment of advanced ovarian cancer, metastatic breast cancer, melanoma, non-small-cell lung cancer, and Kar-posi s sarcoma [8,9], More recently, these drugs have been used for the treatment of neck, prostate, and cervical cancers [8, 9],... 

Carcinogenesis. Skin cancer is the most serious adverse effect of UVR. There are three common types of skin cancer melanoma, basal cell carcinoma (BSC), and squamous cell carcinoma (SCC). BSC and SCC are known collectively as non-melanoma skin cancer (NMSC). BSC is the most common skin... 

Breast cancer NSCLC prostate cancer ovarian cancer SCLC bladder cancer gastric cancer head and neck cancers melanoma soft tissue sarcomas... 

Colon Cancer Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Kidney Cancer Brain Cancer Thyroid Cancer Liver Cancer Pancreatic Cancer Esophageal Cancer Cervical Cancer Oral Cancer Melanoma Leukemia... 

Fibroblast growth factors int-2 Amplification Secreted Breast cancer Bladder cancer Melanoma... 

Three new quassinoid glucosides, bruceoside-D (37), -E (38), and -F (39) were isolated from the same plant, and their structures were elucidated by spectral evidence and chemical transformation to known compounds. Bruceoside-D (37), -E (38), and -F (39) were evaluated for cytotoxicity in the NCI s in vitro human tumor cell line panel, which included 58 cell lines representing nine cancer types. These compounds showed selective cytotoxicity in cell lines of leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, and breast cancer. The log GI50 values (log concentration which reduced cell growth to 50%) ranged from >-4 to -5.72, as shown in Table 2 [18]. 

More than 750 cancer patients in more than a dozen clinical trials around the world have received Oncophage. Many of these patients had advanced disease, including kidney cancer, melanoma, and colon cancer, and had not responded to traditional cancer treatments. 

Data are average values from over 60 human tumor cell lines including leukemia, nonsmall- and smaU-cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, and renal cancer. 

---